Trial intelligence / Profile preview

ANTHEM: Metformin to Slow Aging

NCT04264897Phase 3Completed

Sponsor
Oklahoma Medical Research Foundation
Start
Jul 2020
Primary completion
Mar 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of liquid metformin (Aspargo Labs) in aging, sponsored by Oklahoma Medical Research Foundation. Started Jul 2020; status: completed.

02

Drugs

liquid metformin (Aspargo Labs)
03

Conditions

aging

Beyond the preview

Go deeper on NCT04264897.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04264897.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call